Docetaxel extravasation into the normal breast during breast cancer treatment

Anti-Cancer Drugs

Volumn 15, Issue 4, 2004, Pages 401-404

  El Saghir, Nagi S ^a   Otrock, Zaher K ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Breast; Chemotherapy; Docetaxel; Extravasation; Vesicant

Indexed keywords

ANTIHISTAMINIC AGENT; DOCETAXEL; HYDROCORTISONE; HYDROXYZINE;

ADULT; ARTICLE; BLISTER; BREAST CARCINOMA; BREAST METASTASIS; CANCER LOCALIZATION; CASE REPORT; CENTRAL VENOUS CATHETER; DESQUAMATION; DISEASE COURSE; DRUG INFUSION; EXTRAVASATION; FEMALE; HUMAN; INJECTION PAIN; INJECTION SITE; MAMMARY GLAND; PRIORITY JOURNAL; SKIN IRRITATION; TISSUE INJURY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLISTER; BREAST; BREAST NEOPLASMS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM METASTASIS; TAXOIDS;

EID: 1942485324     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200404000-00013     Document Type: Article

References (10)

1. Raley J, Geisler JP, Buekers TE, Sorosky JI. Docetaxel extravasation causing significant delayed tissue injury. Gynecol Oncol 2000; 78:259-260.
2. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, et al. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 2003; 21: 963-964.
3. O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub J-P, Cervantes G, et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 2002; 20:2812-2823.
4. Langstein HN, Duman H, Seelig D, Butler CE, Evans GR. Retrospective study of the management of chemotherapeutic extravasation injury. Ann Plastic Surg 2002; 49:369-374.
5. Boyle DM, Engelking C. Vesicant extravasation: myths and realities. Oncol Nursing Forum 1995; 22:57-67.
6. Ascherman JA, Knowles SL, Attkiss K. Docetaxel (Taxotere) extravasation: a report of five cases with treatment recommendations. Ann Plastic Surg 2000; 45:438-441.
7. Berghammer P, Pohnl R, Baur M, Dittrich C. Docetaxel extravasation. Supp Care Cancer 2001; 9:131-134.
8. Armand JP. Attitude pratique en cas d'extravasation des anticancereux. Medicaments utilises en cancerologie, 4eme edn. Dossier du Centre National Hospitalier d'Information sur le Medicament; 2001, pp. 38-43.
9. Chrystal C. Administering continuous vesicant chemotherapy in the ambulatory setting. J Intravenous Nursing 1997; 20:78-88.
10. Camp-Sorrell D. Developing extravasation protocols and monitoring outcomes. J Intravenous Nursing 1998; 21:232-239.